COMMUNIQUÉS West-GlobeNewswire

Burcon Announces Execution of Loan Agreement

13/11/2018 - 15:47

VANCOUVER, British Columbia, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU) (“ Burcon ”) announced today that it has entered into a loan agreement (the “ Loan Agreement ”) pursuant to which [...]

Exagen Diagnostics to Present at The Piper Jaffray 30th Annual Heathcare Conference

13/11/2018 - 15:30

Leader in autoimmunity testing to present at upcoming investor conference ALBUQUERQUE, NM and SAN DIEGO, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, today announced [...]

Avalon GloboCare Provides Third Quarter 2018 Business Update; Reports 30% Increase in Revenues

13/11/2018 - 15:05

FREEHOLD, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies, today announced financial results and provided a business update for the [...]

Spine Injury Solutions Announces Financial Results for the Third Quarter and Nine Months Ended September 30, 2018

13/11/2018 - 15:00

HOUSTON, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), announces financial results for the quarter and nine months ended September 30, 2018. Financial Highlights – three month period ended [...]

Advantis Corp. Ups Q4 Guidance, Grows Relationships

13/11/2018 - 15:00

NEWPORT BEACH, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, stated last week that he foresees 20% quarter over quarter revenue growth for the [...]

IASO BioMed Announces Addition of Four Members to Its Scientific Advisory Board

13/11/2018 - 15:00

Company developing a Next Generation Treatment for Low Testosterone CENTENNIAL, Colo., Nov. 13, 2018 (GLOBE NEWSWIRE) -- IASO BioMed, Inc. (“IASO” or the “Company”), an innovative biotechnology company dedicated to [...]

Phoenix Life Sciences International Announces Significant Retirement of Convertible Debt and Elimination of Outstanding Preferred Shares

13/11/2018 - 15:00

DENVER , Nov. 13, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”) (OTC: PLSI), an international adaptive healthcare solutions company, today announced that it has retired additional [...]

Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference

13/11/2018 - 14:45

NEW YORK and CLEVELAND, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

CTD Holdings Engages Torreya Capital as Strategic Advisor

13/11/2018 - 14:43

ALACHUA, Fla., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, [...]

Marrone Bio Innovations’ Venerate Biopesticide Named Best New Biological Product at Agrow Awards 2018 in London

13/11/2018 - 14:31

DAVIS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that Agribusiness [...]

Cellectar Reports Third Quarter 2018 Financial Results and Provides Business Update

13/11/2018 - 14:30

FLORHAM PARK, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (“Cellectar” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and [...]

MedTainer Issues Great Q: North American Picture Emerges

13/11/2018 - 14:30

CORONA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- MedTainer™ Inc. (MDTR-OTCMARKETS) published their 3 rd Quarter 10-Q today and report that gross sales in the quarter have increased approximately 22% compared to 3 rd [...]

NexTech AR Brings Augmented Reality to Cannabis -- CFN Media

13/11/2018 - 14:30

SEATTLE, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

New Data Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) in Evaluation of Hypertension

13/11/2018 - 14:30

NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]

Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries -- CFN Media

13/11/2018 - 14:30

SEATTLE, Nov. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

PSIQ Reports Record Breaking September 30th, 2018 Nine Month Revenue Increase of 850%

13/11/2018 - 14:30

SUNRISE, Fla., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), reported revenues for the nine [...]

Micron Solutions, Inc. Reports 2018 Third Quarter Results

13/11/2018 - 14:27

FITCHBURG, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]

Medtronic Receives CE Mark Approval for the Valiant Navion(TM) Thoracic Stent Graft System

13/11/2018 - 14:01

Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Broadens Treatable Patient Population with Thoracic Aortic Disease DUBLIN - November 13, 2018 - Medtronic plc (NYSE:MDT) today announced it has received [...]

Iovance Biotherapeutics to Participate at November Investor Conferences

13/11/2018 - 14:01

SAN CARLOS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology [...]